City

Beijing (2)

Condition

CAEBV (2)

HLH (1)

PTLD (1)

Overall Status

Enrolling by invitation (1)

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

phase 3 (1)

Sponsor

Beijing Friendship Hospital (2)

Collaborator

Intervention

low-dose cd20 monoclonal antibody injection (1)

selinexol and dexamethasone (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

caebv

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CAEBV Trial in Beijing (Selinexol and Dexamethasone)

Not yet recruiting

CAEBV

Selinexol and Dexamethasone

Beijing, China

Beijing Friendship Hospital, Capital Medical University

Apr 21, 2022

PTLD, CAEBV, HLH Trial in Beijing (low-dose CD20 mAb injection)

Enrolling by invitation

PTLD
+2 more

low-dose CD20 monoclonal antibody injection

Beijing, Beijing, China

Beijing Friendship Hospital

Feb 24, 2022